CreativeOne Wealth’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-40,000
Closed -$221K 678
2023
Q2
$221K Hold
40,000
0.01% 754
2023
Q1
$250K Sell
40,000
-15
-0% -$84 0.01% 686
2022
Q4
$186K Sell
40,015
-1,000
-2% -$4.93K 0.01% 703
2022
Q3
$192K Hold
41,015
0.01% 669
2022
Q2
$243K Buy
41,015
+8,500
+26% +$94.6K 0.01% 620
2022
Q1
$629K Buy
+32,515
New +$746K 0.03% 369
2021
Q4
Sell
-10,515
Closed -$431K 764
2021
Q3
$431K Sell
10,515
-11,500
-52% -$417K 0.03% 443
2021
Q2
$793K Buy
22,015
+5,900
+37% +$218K 0.05% 293
2021
Q1
$629K Buy
16,115
+2,515
+18% +$113K 0.05% 290
2020
Q4
$549K Buy
+13,600
New +$625K 0.05% 270

Other funds holding GDRX

CreativeOne Wealth's GDRX Position: Q3 2023 in Review

CreativeOne Wealth sold out of GoodRx Holdings (GDRX) in Q3 2023, closing a stake of 40,000 shares — an estimated $221K sold.

CreativeOne Wealth first reported a position in GDRX in Q4 2020 and held it in 10 quarters. The position peaked at $793K in Q2 2021. 155 funds tracked by Wall St. Rank hold GDRX as of Q3 2023.

  • CreativeOne Wealth reported no remaining GoodRx Holdings position as of Q3 2023 after selling out during the quarter.
  • CreativeOne Wealth sold 40,000 GoodRx Holdings shares in Q3 2023, an estimated $221K.
  • CreativeOne Wealth first reported a position in GoodRx Holdings in Q4 2020 and held it in 10 quarters.
  • CreativeOne Wealth's GoodRx Holdings position peaked at $793K in Q2 2021.
  • 155 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2023.

Based on CreativeOne Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.